ID   32511
AC   CVCL_E448
SY   TER232; TER-232; Ter 232; TER284; TER-284; Ter 284; TER376; TER-376; Ter 376; TER485; TER-485; Ter 485; Extract 81; Extract 272; Extract 365
DR   dbMHC; 48466
DR   ECACC; 94071436
DR   IHW; IHW09231
DR   IPD-IMGT/HLA; 10137
DR   Wikidata; Q54584839
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/373cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*80:01,02:06; B*18:JV,27:ENN; C*02:02:02; DPB1*01:01:01,05:01; DQA1*01:03,01:04; DQB1*05:03:01,06:03; DRB1*13:01:01,14:54; DRB3*01:01,02:02 (IPD-IMGT/HLA=10137).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001; PMCID=PMC6599558;
RA   Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R.,
RA   Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K.,
RA   Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A.,
RA   Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M.,
RA   Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R.,
RA   Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H.,
RA   Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F.,
RA   Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A.,
RA   Fernandez-Vina M.A.;
RT   "Next-generation HLA typing of 382 International Histocompatibility
RT   Working Group reference B-lymphoblastoid cell lines: report from the
RT   17th International HLA and Immunogenetics Workshop.";
RL   Hum. Immunol. 80:449-460(2019).
//